Related Experiment Video
Updated: Jun 1, 2026

08:57
Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models
Published on: May 17, 2024
Nuclear morphometry identifies a distinct aggressive cellular phenotype in cutaneous squamous cell carcinoma
Evan S Glazer1, Peter H Bartels, Anil R Prasad
1Arizona Cancer Center, University of Arizona, Tucson, AZ, USA.
Cancer Prevention Research (Philadelphia, Pa.)
|June 4, 2011
Summary
Nuclear morphometry, or karyometry, can differentiate aggressive cutaneous squamous cell carcinoma (cSCC) from nonaggressive forms. This method provides a classification score for improved risk stratification in high-risk patients.
Area of Science:
- Oncology
- Dermatopathology
- Quantitative Pathology
Background:
- Cutaneous squamous cell carcinoma (cSCC) poses a risk of recurrence and secondary tumors, necessitating accurate prognostication.
- Identifying aggressive cSCC aids in targeted surveillance and therapy, potentially reducing patient morbidity and mortality.
Purpose of the Study:
- To investigate the utility of nuclear morphometry (karyometry) in distinguishing between aggressive and nonaggressive cSCC.
- To develop a quantitative classification score for risk stratification of cSCC patients.
Main Methods:
- Retrospective analysis of cSCC lesions from 40 male patients, categorized as aggressive (22) or nonaggressive (18).
- Karyometric analysis was performed to identify nuclear features differentiating cSCC subtypes.
- A quantitative aggressive classification score was derived using statistically significant nuclear features (Kruskal-Wallis test, P < 0.0001).
Main Results:
- A mean of 96 nuclei were analyzed per group.
- The mean classification score was significantly higher for aggressive cSCC (69% ± 6%) compared to nonaggressive cSCC (28% ± 5%, P = 0.00002).
- The classification score accurately categorized 80% of patients (P = 0.0004), demonstrating significant discriminatory power.
Conclusions:
- Karyometry effectively differentiates between aggressive and nonaggressive cSCC.
- The derived classification score offers a quantitative measure for individual lesion assessment.
- This quantitative approach holds promise for improving risk stratification in patients with cSCC.

